
### [NCIT:C3686](http://purl.obolibrary.org/obo/NCIT_C3686)
**Label:** Salivary Gland Monomorphic Adenoma

**Subclasses:** [NCIT:C5932](http://purl.obolibrary.org/obo/NCIT_C5932) (Salivary Gland Oncocytoma), [NCIT:C6845](http://purl.obolibrary.org/obo/NCIT_C6845) (Oral Cavity Monomorphic Adenoma), [NCIT:C35738](http://purl.obolibrary.org/obo/NCIT_C35738) (Salivary Gland Sebaceous Adenoma), [NCIT:C6847](http://purl.obolibrary.org/obo/NCIT_C6847) (Parotid Gland Monomorphic Adenoma), [NCIT:C5950](http://purl.obolibrary.org/obo/NCIT_C5950) (Salivary Gland Basal Cell Adenoma), 

**Class expressions from DL-Learner:**

- [NCIT:C41608](http://purl.obolibrary.org/obo/NCIT_C41608) (Endocrine-Stromal Cell) 53.33%
- [NCIT:C40557](http://purl.obolibrary.org/obo/NCIT_C40557) (Metastatic Lesion) 53.33%
- [NCIT:C36117](http://purl.obolibrary.org/obo/NCIT_C36117) (Invasive Lesion) 53.33%
- [NCIT:C36116](http://purl.obolibrary.org/obo/NCIT_C36116) (Borderline Lesion) 53.33%
- Thing 53.10%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) 38.69%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38995](http://purl.obolibrary.org/obo/NCIT_C38995) (Angiotensin II Signaling Pathway))) 38.69%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38992](http://purl.obolibrary.org/obo/NCIT_C38992) (Ribosomal Biogenesis Pathway))) 38.69%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38981](http://purl.obolibrary.org/obo/NCIT_C38981) (AKT Signaling Pathway))) 38.69%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38975](http://purl.obolibrary.org/obo/NCIT_C38975) (Agrin Pathway))) 38.69%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38971](http://purl.obolibrary.org/obo/NCIT_C38971) (Regulation of Apoptosis Pathway))) 38.69%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C3892](http://purl.obolibrary.org/obo/NCIT_C3892) (Mu Heavy Chain Disease))) 38.69%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38850](http://purl.obolibrary.org/obo/NCIT_C38850) (Phosphatidylinositol Signaling System Pathway))) 38.69%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38834](http://purl.obolibrary.org/obo/NCIT_C38834) (MAPK Signaling Pathway))) 38.69%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C38829](http://purl.obolibrary.org/obo/NCIT_C38829) (Focal Adhesion Pathway))) 38.69%


